These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 8118648)

  • 21. Inhaled nitric oxide attenuates pulmonary inflammation and fibrin deposition and prolongs survival in neonatal hyperoxic lung injury.
    ter Horst SA; Walther FJ; Poorthuis BJ; Hiemstra PS; Wagenaar GT
    Am J Physiol Lung Cell Mol Physiol; 2007 Jul; 293(1):L35-44. PubMed ID: 17384081
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene expression profile and histopathology of experimental bronchopulmonary dysplasia induced by prolonged oxidative stress.
    Wagenaar GT; ter Horst SA; van Gastelen MA; Leijser LM; Mauad T; van der Velden PA; de Heer E; Hiemstra PS; Poorthuis BJ; Walther FJ
    Free Radic Biol Med; 2004 Mar; 36(6):782-801. PubMed ID: 14990357
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanical ventilation affects alveolar fibrinolysis in LPS-induced lung injury.
    Dahlem P; Bos AP; Haitsma JJ; Schultz MJ; Wolthuis EK; Meijers JC; Lachmann B
    Eur Respir J; 2006 Nov; 28(5):992-8. PubMed ID: 16837499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surfactant protein-A deficiency in a primate model of bronchopulmonary dysplasia.
    King RJ; Coalson JJ; deLemos RA; Gerstmann DR; Seidner SR
    Am J Respir Crit Care Med; 1995 Jun; 151(6):1989-97. PubMed ID: 7767549
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhanced tissue factor pathway activity and fibrin turnover in the alveolar compartment of patients with interstitial lung disease.
    Günther A; Mosavi P; Ruppert C; Heinemann S; Temmesfeld B; Velcovsky HG; Morr H; Grimminger F; Walmrath D; Seeger W
    Thromb Haemost; 2000 Jun; 83(6):853-60. PubMed ID: 10896238
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Highly stable plasminogen activator inhibitor type one (VLHL PAI-1) protects fibrin clots from tissue plasminogen activator-mediated fibrinolysis.
    Jankun J; Aleem AM; Selman SH; Skrzypczak-Jankun E; Lysiak-Szydlowska W; Grafos N; Fryer HJ; Greenfield RS
    Int J Mol Med; 2007 Nov; 20(5):683-7. PubMed ID: 17912461
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of intra-abdominal administration of recombinant tissue plasminogen activator on coagulation, fibrinolysis and inflammatory responses in experimental polymicrobial peritonitis.
    van Veen SQ; Meijers JC; Levi M; van Gulik TM; Boermeester MA
    Shock; 2007 May; 27(5):534-41. PubMed ID: 17438459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in pulmonary tissue structure and KL-6/MUC1 expression in a newborn rat model of hyperoxia-induced bronchopulmonary dysplasia.
    Zhu Y; Fu J; You K; Jin L; Wang M; Lu D; Xue X
    Exp Lung Res; 2013 Dec; 39(10):417-26. PubMed ID: 24298937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diffuse alveolar damage in the evolution of bronchopulmonary dysplasia in the baboon.
    Coalson JJ; Kuehl TJ; Prihoda TJ; deLemos RA
    Pediatr Res; 1988 Sep; 24(3):357-66. PubMed ID: 3211622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased activity of interleukin-6 but not tumor necrosis factor-alpha in lung lavage of premature infants is associated with the development of bronchopulmonary dysplasia.
    Bagchi A; Viscardi RM; Taciak V; Ensor JE; McCrea KA; Hasday JD
    Pediatr Res; 1994 Aug; 36(2):244-52. PubMed ID: 7970941
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cleavage of surfactant-incorporating fibrin by different fibrinolytic agents. Kinetics of lysis and rescue of surface activity.
    Günther A; Markart P; Kalinowski M; Ruppert C; Grimminger F; Seeger W
    Am J Respir Cell Mol Biol; 1999 Dec; 21(6):738-45. PubMed ID: 10572071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fibrin deposition in tissues from endotoxin-treated mice correlates with decreases in the expression of urokinase-type but not tissue-type plasminogen activator.
    Yamamoto K; Loskutoff DJ
    J Clin Invest; 1996 Jun; 97(11):2440-51. PubMed ID: 8647936
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pentoxifylline reduces fibrin deposition and prolongs survival in neonatal hyperoxic lung injury.
    ter Horst SA; Wagenaar GT; de Boer E; van Gastelen MA; Meijers JC; Biemond BJ; Poorthuis BJ; Walther FJ
    J Appl Physiol (1985); 2004 Nov; 97(5):2014-9. PubMed ID: 15208286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Abnormalities of pathways of fibrin turnover in the human pleural space.
    Idell S; Girard W; Koenig KB; McLarty J; Fair DS
    Am Rev Respir Dis; 1991 Jul; 144(1):187-94. PubMed ID: 2064128
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in procoagulant and fibrinolytic gene expression during bleomycin-induced lung injury in the mouse.
    Olman MA; Mackman N; Gladson CL; Moser KM; Loskutoff DJ
    J Clin Invest; 1995 Sep; 96(3):1621-30. PubMed ID: 7544811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.
    Munkvad S
    Dan Med Bull; 1993 Sep; 40(4):383-408. PubMed ID: 8222763
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma tissue-type plasminogen activator increases fibrinolytic activity of exogenous urokinase-type plasminogen activator.
    Shenkman B; Livnat T; Budnik I; Tamarin I; Einav Y; Martinowitz U
    Blood Coagul Fibrinolysis; 2012 Dec; 23(8):729-33. PubMed ID: 22918041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased procoagulant and antifibrinolytic activities in the lungs with idiopathic pulmonary fibrosis.
    Kotani I; Sato A; Hayakawa H; Urano T; Takada Y; Takada A
    Thromb Res; 1995 Mar; 77(6):493-504. PubMed ID: 7624837
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Short-term effect of surgical trauma on rat peritoneal fibrinolytic activity and its role in adhesion formation.
    Hellebrekers BW; Trimbos-Kemper GC; Bakkum EA; Trimbos JB; Declerck PJ; Kooistra T; Emeis JJ
    Thromb Haemost; 2000 Nov; 84(5):876-81. PubMed ID: 11127871
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early high dose antioxidant vitamins do not prevent bronchopulmonary dysplasia in premature baboons exposed to prolonged hyperoxia: a pilot study.
    Berger TM; Frei B; Rifai N; Avery ME; Suh J; Yoder BA; Coalson JJ
    Pediatr Res; 1998 Jun; 43(6):719-26. PubMed ID: 9621979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.